Effects of Vinorelbine on M2 Macrophages in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences · 03.03.2025 · 26 (5) · 2252
DOI: 10.3390/ijms26052252 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2025. Verfasst von Ahmed Al-Omar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Institute of Health Sciences, Ege University, Bornova 35100, Izmir, Turkey. Hauptthemen laut MEDLINE: Vinorelbine, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Macrophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ege University, Scientific Research Projects.
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) significantly influence tumor progression and patient responses to conventional chemotherapy. However, the interplay between anti-cancer drugs, immune responses in the tumor microenvironment, and their implications for cancer treatment remains poorly understood. This study investigates the effects of vinorelbine on M2 macrophages in lung cancer and its capacity to modulate TAMs toward an M1 phenotype. Peripheral blood mononuclear cells (PBMCs) were polarized into M2 macrophages, and subsequent phenotype alterations upon vinorelbine treatment were assessed. Additionally, we evaluated vinorelbine’s impact on gene and protein expression associated with cancer progression and cell invasion in non-small-cell lung cancer (NSCLC) cells indirectly co-cultured with M2 macrophages. Notably, vinorelbine, particularly at low concentrations, reprogrammed M2 macrophages to exhibit M1-like characteristics. While M2 macrophages enhanced cancer cell invasion, vinorelbine significantly mitigated this effect. M2 macrophages led to the overexpression of numerous genes linked to tumor growth, angiogenesis, invasion, and immune suppression in NSCLC cells, increasing the BCL2/BAX ratio and promoting cellular resistance to apoptosis. The anti-tumor efficacy of vinorelbine appears to be partly attributed to the reprogramming of M2 macrophages to the M1 phenotype, suggesting that low-dose vinorelbine may optimize therapeutic outcomes while minimizing toxicity in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Oncology, Institute of Health Sciences, Ege University, Bornova 35100, Izmir, Turkey.
- Atatürk Health Care Vocational School, Ege University, Bornova 35100, Izmir, Turkey.
- Translational Pulmonary Research Group (EGESAM), Ege University, Bornova 35100, Izmir, Turkey.
- Department of Pulmonary Medicine, Faculty of Medicine, Ege University, Bornova 35100, Izmir, Turkey.
- Department of Parasitology, Faculty of Medicine, Ege University, Bornova 35100, Izmir, Turkey.
ORCID-Profile: Can Muftuoglu, Ayse Caner
Förderung
- Ege University, Scientific Research Projects
Zitieren
APA
Al-Omar, A., Asadi, M., Mert, U., Muftuoglu, C., Karakus, H. S., Goksel, T., & Caner, A. (2025). Effects of Vinorelbine on M2 Macrophages in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 26(5), 2252. https://doi.org/10.3390/ijms26052252
Vancouver
Al-Omar A, Asadi M, Mert U, Muftuoglu C, Karakus HS, Goksel T, et al. Effects of Vinorelbine on M2 Macrophages in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025;26(5):2252. doi:10.3390/ijms26052252
BibTeX
@article{AlOmar2025,
author = {Al-Omar, Ahmed and Asadi, Milad and Mert, Ufuk and Muftuoglu, Can and Karakus, Haydar Soydaner and Goksel, Tuncay and Caner, Ayse},
title = {Effects of Vinorelbine on M2 Macrophages in Non-Small Cell Lung Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {2252},
doi = {10.3390/ijms26052252}
}
EUVIMED